ストックスクリーナーアプリを入手
0.6096
1.68%
-0.0104
プレマーケット:
.62
0.0104
+1.71%
Tenaya Therapeutics Inc (TNYA) 最新ニュース
TNYA News | TENAYA THERAPEUTICS INC (NASDAQ:TNYA) - ChartMill
TENAYA THERAPEUTICS INC (TNYA) Stock Chart - ChartMill
Tenaya Therapeutics, Inc.(NasdaqCM: TNYA) added to S&P Global BMI Index - marketscreener.com
Tenaya Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy Designation for TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy - investingnews.com
Tenaya Therapeutics Grants 49,000 Shares to CMO Tingley Whittemore (NASDAQ: TNYA) - Kalkine Media
Tenaya Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy - GlobeNewswire
Tenaya Therapeutics CEO Ali Faraz Receives 122,000 Shares and 732,500 Derivative Securities at No Cost (NASDAQ: TNYA) - Kalkine Media
More than 70,000 people in the U.S. are estimated to have a genetic heart condition. A gene therapy for it received special FDA status. - Stock Titan
Tenaya at H.C. Wainwright conference: gene therapy data build By Investing.com - Investing.com UK
A heart-disease biotech will meet investors at two September conferences - Stock Titan
Tenaya Therapeutics (TNYA) Stock Holds Near $0.69 Support Zone as Biotech Faces Key Technical TestMESA MA - siam.in
Tenaya Therapeutics Announces Interim Data from MyPEAK™-1 Showing Treatment of MYBPC3-associated HCM with TN-201 Gene Therapy Resulted in Consistent Signs of Cardiac Remodeling and Reductions in Symptoms - Barchart.com
Israel Englander group takes passive stake in Tenaya Therapeutics (TNYA) - stocktitan.net
Tenaya Therapeutics (TNYA) Falls 3.85% to $0.70 as Shares Approach Critical SupportSynthetic Long - vinanet.vn
Tenaya Therapeutics Eyes Q4 Updates for Cardiac Gene Therapies, TN-301 - MarketBeat
Tenaya therapeutics CEO Ali Faraz sells $15.8k in company shares By Investing.com - Investing.com Australia
Tenaya therapeutics CMO Tingley Whittemore sells $5,267 in stock By Investing.com - Investing.com Nigeria
Tenaya therapeutics CEO Ali Faraz sells $15.8k in company shares - Investing.com
Tenaya therapeutics CMO Tingley Whittemore sells $5,267 in stock - Investing.com
Tenaya Therapeutics (NASDAQ:TNYA) CEO Sells $15,784.72 in Stock - MarketBeat
Tenaya Therapeutics, Inc. SEC Filing (Aug 18, 2026) - Stock Titan
GSA Capital Partners LLP Makes New $1.97 Million Investment in Tenaya Therapeutics, Inc. $TNYA - MarketBeat
Tenaya Therapeutics (NASDAQ: TNYA) CEO sells 22K shares to cover RSU taxes - Stock Titan
Tenaya Therapeutics (TNYA) Q2 2026 Earnings: EPS Misses by 186.94% as Clinical-Stage Pipeline Drives Wider-Than-Expected LossRevenue Recognition Risk - vinanet.vn
symbol__ Stock Quote Price and Forecast - CNN
Transcript : Tenaya Therapeutics, Inc. Presents at Canaccord Genuity's 46th Annual Growth Conference, Aug-11-2026 12 - marketscreener.com
Tenaya Therapeutics (TNYA) Institutional Ownership 2026 - MarketBeat
Tenaya Therapeutics (TNYA) Drops 4% to $0.73 — Testing Crucial Support ZoneADD Alert - Vinanet
TNYA Q2 2026 Earnings: Wider-Than-Expected Loss as Shares Climb on Pipeline OptimismDiluted EPS Report - vinanet.vn
Tenaya Therapeutics at Canaccord Genuity conference: q4 catalysts loom By Investing.com - Investing.com Canada
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Average Recommendation of "Moderate Buy" by Brokerages - marketbeat.com
Renaissance Technologies LLC Increases Stock Holdings in Tenaya Therapeutics, Inc. $TNYA - MarketBeat
HC Wainwright Has Positive Outlook of TNYA FY2026 Earnings - MarketBeat
Q3 Earnings Forecast for TNYA Issued By HC Wainwright - MarketBeat
H.C. Wainwright Maintains Tenaya Therapeutics(TNYA.US) With Buy Rating, Maintains Target Price $3 - Moomoo
William Blair Maintains Tenaya Therapeutics(TNYA.US) With Buy Rating - moomoo.com
Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times
Tenaya Therapeutics (NASDAQ:TNYA) Issues Quarterly Earnings Results - MarketBeat
Tenaya Therapeutics (TNYA) Gains 5.81% as Biotech Stock Holds Above Critical $0.74 SupportZero Gamma Level - dars.gov.et
Tenaya Therapeutics, Inc. reports results for the quarter ended June 30Earnings Summary - tradingview.com
Tenaya Therapeutics Q2 net loss widens on impairment charge - TradingView
Tenaya Therapeutics (TNYA) Jumps 5.8% to $0.78 as It Tests Key Resistance at $0.82Calendar Spread Trade - dars.gov.et
Tenaya Therapeutics (TNYA) to Post Earnings on Wednesday - MarketBeat
Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference - The Manila Times
Tenaya CFO Eric Hyllengren to Speak at Boston Conference - Stock Titan
Tenaya Therapeutics (TNYA) Steadies Above $0.70 Support as Trading Volume Signals Cautious SentimentStock News - careplusvn.com
Tenaya Therapeutics (TNYA) Slips to $0.74 as Key Support at $0.70 Comes into FocusMutual Fund Flow - careplusvn.com
Tenaya Therapeutics Inc (TNYA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Tenaya Therapeutics Inc (TNYA) Valuation: PE, PB & Fair Value Analysis - TradingKey
TNYA|Tenaya Therapeutics Inc|Price:0.769|Chg%:-0.006 - TradingKey
Tenaya Therapeutics Inc (TNYA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Tenaya Therapeutics Inc (TNYA) Cash Flow - TradingKey
Tenaya Therapeutics, Inc. Revenue Breakdown – NASDAQ:TNYA - TradingView
Tenaya Therapeutics Inc (TNYA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Tenaya Therapeutics Inc (TNYA) Institutional Confidence - TradingKey
Tenaya Therapeutics (TNYA) Holds Near Support as Micro-Cap Biotech Seeks DirectionLast Point Resistance - careplusvn.com
Tenaya Therapeutics (TNYA) Q1 2026 Earnings: Wider Loss but Stock Gains as Pipeline Progress Offsets Financial MissEPS Guidance Update - dars.gov.et
Tenaya Therapeutics (TNYA) Edges Higher Amid Consolidation Near SupportStop Loss Guidance - careplusvn.com
Tenaya Therapeutics Q1 2026 Earnings: Slight EPS Miss as Pre-Revenue Biotech Advances Heart Disease Pipeline - dars.gov.et
3.06%
2.55%
大文字化:
|
ボリューム (24 時間):